Long-term follow-up for type 1 (subretinal pigment epithelium) neovascularization using a modified "treat and extend" dosing regimen of intravitreal antivascular endothelial growth factor therapy.

作者: Michael Engelbert , Sandrine A Zweifel , K Bailey Freund

DOI: 10.1097/IAE.0B013E3181D50CBF

关键词:

摘要: Purpose:The purpose of the study was to analyze long-term outcomes for treatment type 1 (subretinal pigment epithelium) neovascularization using a modified “treat and extend” antivascular endothelial growth factor dosing regimen.Methods:We performed retrospective, noncomparative analysis

参考文章(16)
G. Lo Giudice, V. De Belvis, S. Piermarocchi, A. Galan, G. Prosdocimo, Acute visual loss and chorioretinal infarction after photodynamic therapy combined with intravitreal triamcinolone. European Journal of Ophthalmology. ,vol. 18, pp. 652- 655 ,(2008) , 10.1177/112067210801800429
U. Schmidt-Erfurth, C. G. Kiss, S. Michels, C. Simader, J. Wagner, Effect of Photodynamic Therapy (PDT) and Ranibizumab on Vascular Anatomy and Retinal Function in Neovascular Age-Related Macular Degeneration Investigative Ophthalmology & Visual Science. ,vol. 48, pp. 4544- 4544 ,(2007)
FELICE CARDILLO PICCOLINO, CHIARA M. EANDI, LUCA VENTRE, ROBERTA C. RIGAULT DE LA LONGRAIS, FEDERICO M. GRIGNOLO, Photodynamic therapy for chronic central serous chorioretinopathy. Retina-the Journal of Retinal and Vitreous Diseases. ,vol. 23, pp. 752- 763 ,(2003) , 10.1097/00006982-200312000-00002
JONATHAN P. LEVINE, INNA MARCUS, JOHN A. SORENSON, RICHARD F. SPAIDE, MICHAEL J. COONEY, K BAILEY FREUND, Macular hemorrhage in neovascular age-related macular degeneration after stabilization with antiangiogenic therapy. Retina-the Journal of Retinal and Vitreous Diseases. ,vol. 29, pp. 1074- 1079 ,(2009) , 10.1097/IAE.0B013E3181B09443
Anne E. Fung, Geeta A. Lalwani, Philip J. Rosenfeld, Sander R. Dubovy, Stephan Michels, William J. Feuer, Carmen A. Puliafito, Janet L. Davis, Harry W. Flynn, Maria Esquiabro, An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. American Journal of Ophthalmology. ,vol. 143, pp. 566- 583 ,(2007) , 10.1016/J.AJO.2007.01.028
Gregory R. Blaha, F. Denton Wertz, Jeffrey L. Marx, Profound choroidal hypoperfusion after combined photodynamic therapy and intravitreal triamcinolone acetonide. Ophthalmic Surgery Lasers & Imaging. ,vol. 39, pp. 6- 11 ,(2008) , 10.3928/15428877-20080101-02
Geeta A. Lalwani, Philip J. Rosenfeld, Anne E. Fung, Sander R. Dubovy, Stephen Michels, William Feuer, Janet L. Davis, Harry W. Flynn, Maria Esquiabro, A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study American Journal of Ophthalmology. ,vol. 148, pp. 43- 58.e1 ,(2009) , 10.1016/J.AJO.2009.01.024
FRANCO M. RECCHIA, SHAREEN GREENBAUM, CYNTHIA A. CARVALHO RECCHIA, ALAN J. RUBY, CLARON D. ALLDREDGE, TAREK S. HASSAN, Self-reported acute decrease in visual acuity after photodynamic therapy for age-related macular degeneration. Retina-the Journal of Retinal and Vitreous Diseases. ,vol. 26, pp. 1042- 1048 ,(2006) , 10.1097/01.IAE.0000254894.94013.D8